144 related articles for article (PubMed ID: 37823951)
1. MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1.
Huang S; Xiao X; Wu H; Zhou F; Fu C
Ir J Med Sci; 2024 Apr; 193(2):909-916. PubMed ID: 37823951
[TBL] [Abstract][Full Text] [Related]
2. MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes.
Ma N; Hou A; Pan X; Sun F; Xu X; Yu C; Lai R; Huang R; Gong L; Xie Q; Chen J; Ren J
Int J Biol Sci; 2023; 19(11):3456-3471. PubMed ID: 37496991
[TBL] [Abstract][Full Text] [Related]
3. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
4. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3.
Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y
J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753
[TBL] [Abstract][Full Text] [Related]
5. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
Wu SM; Li TH; Yun H; Ai HW; Zhang KH
Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
[TBL] [Abstract][Full Text] [Related]
6. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
[TBL] [Abstract][Full Text] [Related]
7. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
8. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
Fu J; Wu B; Zhong S; Deng W; Lin F
Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
[TBL] [Abstract][Full Text] [Related]
9.
Liu L; Deng L; Wei W; Li C; Lu Y; Bai J; Li L; Zhang H; Jin N; Li C; Zhao C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762300
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
Okina Y; Sato-Matsubara M; Matsubara T; Daikoku A; Longato L; Rombouts K; Thanh Thuy LT; Ichikawa H; Minamiyama Y; Kadota M; Fujii H; Enomoto M; Ikeda K; Yoshizato K; Pinzani M; Kawada N
J Hepatol; 2020 Oct; 73(4):882-895. PubMed ID: 32330605
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
Yang YL; Kuo HC; Wang FS; Huang YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
[TBL] [Abstract][Full Text] [Related]
12. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
Meroni M; Longo M; Erconi V; Valenti L; Gatti S; Fracanzani AL; Dongiovanni P
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671785
[TBL] [Abstract][Full Text] [Related]
13.
Tian G; Wang W; Xia E; Chen W; Zhang S
Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985
[TBL] [Abstract][Full Text] [Related]
14. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.
Xiao J; Xiang H; Xiang H; Sun Z; Xu J; Ren H; Hu P; Peng M
Eur J Pharmacol; 2023 Dec; 960():176113. PubMed ID: 37838102
[TBL] [Abstract][Full Text] [Related]
15. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.
Johnson K; Leary PJ; Govaere O; Barter MJ; Charlton SH; Cockell SJ; Tiniakos D; Zatorska M; Bedossa P; Brosnan MJ; Cobbold JF; Ekstedt M; Aithal GP; Clément K; Schattenberg JM; Boursier J; Ratziu V; Bugianesi E; Anstee QM; Daly AK; ;
JHEP Rep; 2022 Feb; 4(2):100409. PubMed ID: 35072021
[TBL] [Abstract][Full Text] [Related]
16. Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.
Chen D; Xiong J; Chen G; Zhang Z; Liu Y; Xu J; Xu H
In Vivo; 2023; 37(5):2105-2127. PubMed ID: 37652508
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
18. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
[TBL] [Abstract][Full Text] [Related]
19. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
20. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver.
Liao J; Cao Y; Zhao J; Yu B; Wang Y; Li W; Li H; Lv S; Wen W; Cui H; Chen Y
Phytomedicine; 2023 Sep; 118():154937. PubMed ID: 37393831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
